Recent Finacing
Recent Raise
AltrixBio is a biopharmaceutical company developing AJN 003, an oral therapy that mimics bariatric surgery to treat type 2 diabetes and other metabolic diseases.
Focus Areas
Total Raised
Funding round
See the team members at AltrixBio.
